-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LZt6yYvrk4jqZcMLeow+BUqjsJBil7MMzBVNbDMyBIpS2L4QjOorqEMfyNd4ie9P 8i7v/8wZczZY0SA+5jvoHQ== /in/edgar/work/20000815/0000929624-00-001188/0000929624-00-001188.txt : 20000922 0000929624-00-001188.hdr.sgml : 20000921 ACCESSION NUMBER: 0000929624-00-001188 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000815 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INKINE PHARMACEUTICAL CO INC CENTRAL INDEX KEY: 0000929547 STANDARD INDUSTRIAL CLASSIFICATION: [2834 ] IRS NUMBER: 133754005 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-47845 FILM NUMBER: 703013 BUSINESS ADDRESS: STREET 1: 1720 WALTON RD STREET 2: SUITE 200 CITY: BLUE BELL STATE: PA ZIP: 19422 BUSINESS PHONE: 6102609350 MAIL ADDRESS: STREET 1: 1720 WALTON RD STREET 2: SUITE 200 CITY: BLUE BELL STATE: PA ZIP: 19422 FORMER COMPANY: FORMER CONFORMED NAME: PANAX PHARMACEUTICAL CO LTD DATE OF NAME CHANGE: 19940906 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: VERON INTERNATIONAL LTD CENTRAL INDEX KEY: 0001019354 STANDARD INDUSTRIAL CLASSIFICATION: [ ] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: C/O COBLENTZ PATCH DUFFY & BASS LLP STREET 2: 222 KEARNEY STREET 7TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 MAIL ADDRESS: STREET 1: C/O COBLENTZ PATCH DUFFY & BASS LLP STREET 2: 222 KEARNY STREET 7TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 SC 13G 1 0001.txt SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. ______)* InKine Pharmaceuticals Company, Inc. ------------------------------------------------------------- (Name of Issuer) Common Stock ------------------------------------------- (Title of Class of Securities) 457214104 ----------------------------------- (CUSIP Number) Check the following box if a fee is being paid with this statement [_]. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 4 Pages - ------------------------------------------------------------------------------ NAME OF REPORTING PERSON 1. S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS Veron International Limited ("Veron") N.A. - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 2. (a) [_] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3. - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 4. British Virgin Islands - ------------------------------------------------------------------------------ SOLE VOTING POWER 5. NUMBER OF 872,000 shares SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 6. 0 OWNED BY ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 7. REPORTING 872,000 shares PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 8. 0 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 9. 872,000 shares - ------------------------------------------------------------------------------ CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 10. - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 11. 3.77% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON* 12. CO - ------------------------------------------------------------------------------ Page 2 of 4 pages Veron International Limited (the "Reporting Person") hereby makes the following statement on Schedule 13G with respect to certain shares of common stock of InKine Pharmaceutical Company, Inc. (the "Issuer"): Item 1. (a) Name of Issuer; InKine Pharmaceutical Company,Inc. (b) Address of Issuer's Principal Executive Offices Sentry Park East 1720 Walton Road, Suite 200 Blue Bell, PA 19422 Item 2. (a) Name of Person(s) Filing: Veron International Limited (b) Address of Principal Business Office or, if none, Residence: Top Floor, Chinachem Golden Plaza 77 Mody Road Tsimshatsui East Kowloon, Hong Kong (c) Citizenship: British Virgin Islands (d) Title of Class of Securities: This statement relates to shares of common stock, par value $0.0001 per share (the "Common Stock"), of the Issuer. (e) CUSIP Number: 457214104 Item 3. If this statement is filed pursuant to Rule 13d-1(b) or 13d-2(b), check whether the person filing is a: N.A. Item 4. Ownership (a) Amount Beneficially Owned: 872,000 shares (b) Percent of Class: 3.77% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 872,000 shares (ii) shared power to vote or to direct the vote 0 Page 3 of 4 pages (iii) sole power to dispose or to direct the disposition of 872,000 shares (iv) shared power to dispose or to direct the disposition of 0 In January 2000, the Reporting Person sold 628,000 shares out of its total holding of 1,500,000 shares of Common Stock. No other transactions have occurred since January 2000. Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]. Item 6. Ownership of More than Five Percent on Behalf of Another Person. N.A. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company N.A. Item 8. Identification and Classification of Members of the Group N.A. Item 9. Notice of Dissolution of Group N.A. Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purposes or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. August 15, 2000 --------------- Date Veron International Limited /s/ Joseph W.K. Leung --------------------- Joseph W. K. Leung, Director Page 4 of 4 pages ATTENTION: INTENTIONAL MISSTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDERAL CRIMINAL VIOLATIONS (SEE 18 U.S.C. 1001) -----END PRIVACY-ENHANCED MESSAGE-----